Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
(FY)Jul 20, 2024 | (FY)Jul 20, 2023 | (FY)Jul 20, 2022 | (FY)Jul 20, 2021 | (FY)Jul 20, 2020 | (FY)Jul 20, 2019 | (FY)Jul 20, 2018 | (FY)Jul 20, 2017 | (FY)Jul 20, 2016 | (FY)Jul 20, 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | -48.16%5.2B | 1,061.17%10.03B | -104.44%-1.04B | 79.15%23.49B | 111.83%13.11B | 440.05%6.19B | -134.14%-1.82B | -30.12%5.33B | 17.51%7.63B | -6.56%6.49B |
Net profit before non-cash adjustment | 11.74%10.28B | 15.51%9.2B | -27.43%7.97B | 65.85%10.98B | 59.97%6.62B | 29.36%4.14B | -4.59%3.2B | -6.21%3.35B | 94.45%3.57B | -42.09%1.84B |
Total adjustment of non-cash items | -40.45%1.48B | 401.42%2.48B | -80.70%494M | -22.41%2.56B | -37.45%3.3B | 170.27%5.27B | 3.50%1.95B | 22.16%1.89B | -58.65%1.54B | 38.38%3.73B |
-Depreciation and amortization | -0.63%1.89B | 4.06%1.9B | -21.32%1.82B | 8.12%2.32B | 7.74%2.14B | 1.79%1.99B | 13.01%1.95B | 18.67%1.73B | -9.45%1.46B | -2.66%1.61B |
-Reversal of impairment losses recognized in profit and loss | -50.00%3M | -70.00%6M | 81.82%20M | -98.96%11M | 13,175.00%1.06B | -38.46%8M | -31.58%13M | -92.24%19M | -77.61%245M | 1,157.47%1.09B |
-Assets reserve and write-off | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 195.24%20M | 99.66%-21M |
-Share of associates | 29.27%-87M | -44.71%-123M | 60.47%-85M | -186.67%-215M | -66.67%-75M | 10.00%-45M | -78.57%-50M | -175.68%-28M | -7.50%37M | 176.92%40M |
-Disposal profit | -92.21%-148M | 46.15%-77M | -561.29%-143M | -79.74%31M | 1,430.00%153M | -73.68%10M | 533.33%38M | --6M | --0 | 82.78%-36M |
-Pension and employee benefit expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -61.64%112M | --292M |
-Other non-cash items | -123.00%-178M | 169.05%774M | -370.12%-1.12B | 2,666.67%415M | -99.55%15M | 82,875.00%3.31B | -102.52%-4M | 148.48%159M | -143.50%-328M | -89.72%754M |
Changes in working capital | -297.52%-6.56B | 82.62%-1.65B | -195.49%-9.5B | 211.85%9.95B | 199.01%3.19B | 53.80%-3.22B | -7,519.15%-6.97B | -96.26%94M | 172.45%2.51B | -14.39%922M |
-Change in receivables | -2,415.83%-8.78B | 106.40%379M | -40.60%-5.92B | -364.90%-4.21B | 86.36%-906M | -244.81%-6.64B | -779.45%-1.93B | -114.61%-219M | 207.61%1.5B | -8.07%-1.39B |
-Change in inventory | 113.27%373M | -292.46%-2.81B | -135.06%-716M | 437.52%2.04B | 88.48%-605M | -1,950.00%-5.25B | 117.42%284M | -261.42%-1.63B | -116.09%-451M | 46,816.67%2.8B |
-Change in payables | 118.24%2.66B | 939.31%1.22B | -104.90%-145M | -22.32%2.96B | -36.78%3.81B | 204.51%6.02B | -395.39%-5.76B | -18.27%1.95B | 323.71%2.39B | -144.98%-1.07B |
-Change in accrued expense | -98.47%6M | 167.70%392M | -146.88%-579M | 430.04%1.24B | --233M | ---- | ---- | ---- | -259.41%-923M | --579M |
-Provision for loans, leases and other losses | -17.66%-633M | 11.51%-538M | -126.02%-608M | 2,496.67%2.34B | -45.78%90M | 55.14%166M | -15.75%107M | --127M | ---- | ---- |
-Changes in other current assets | 35.40%-188M | 80.97%-291M | -127.36%-1.53B | 880.35%5.59B | -77.05%570M | 666.67%2.48B | 340.00%324M | ---135M | ---- | ---- |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | 0.00%-60M | -1.69%-60M | 25.32%-59M | -43.64%-79M | 9.84%-55M | 14.08%-61M | 14.46%-71M | 27.83%-83M | 18.44%-115M | -11.02%-141M |
Interest received (cash flow from operating activities) | 21.73%605M | 8.99%497M | 20.95%456M | -4.56%377M | 32.55%395M | 20.65%298M | 6.01%247M | 13.11%233M | 4.57%206M | 12.57%197M |
Tax refund paid | 72.06%-892M | 26.17%-3.19B | -30.00%-4.33B | -56.20%-3.33B | -141.22%-2.13B | -6.13%-883M | 4.48%-832M | -6.61%-871M | 30.59%-817M | -43.01%-1.18B |
Other operating cash inflow (outflow) | 0 | 0 | -44,200.00%-443M | -1M | 0 | 0 | 0 | 0 | 200.00%1M | -200.00%-1M |
Operating cash flow | -33.28%4.85B | 234.26%7.27B | -126.47%-5.41B | 80.72%20.46B | 104.22%11.32B | 323.87%5.54B | -153.71%-2.48B | -33.23%4.61B | 28.57%6.9B | -13.02%5.37B |
Investing cash flow | ||||||||||
Net PPE purchase and sale | 5.97%-677M | -17.84%-720M | -167.98%-611M | 64.60%-228M | -60.60%-644M | 38.96%-401M | -53.15%-657M | 20.70%-429M | -26.70%-541M | -2,746.67%-427M |
Net intangibles purchase and sale | -5.34%-1.3B | 24.40%-1.24B | -61.24%-1.64B | 2.50%-1.01B | 1.14%-1.04B | 20.12%-1.05B | 5.25%-1.32B | 8.91%-1.39B | -25.18%-1.53B | 7.30%-1.22B |
Net investment product transactions | 104.02%113M | -3,524.39%-2.81B | 582.35%82M | 92.77%-17M | 66.76%-235M | -301.70%-707M | 44.83%-176M | -209.71%-319M | 93.16%-103M | -1,548.08%-1.51B |
Advance cash and loans provided to other parties | -128.57%-112M | 62.88%-49M | -73.68%-132M | 47.22%-76M | -65.52%-144M | -19.18%-87M | 71.60%-73M | -57.67%-257M | -5,333.33%-163M | 94.44%-3M |
Repayment of advance payments to other parties and cash income from loans | 10.90%173M | -8.77%156M | 11.04%171M | -62.07%154M | 86.24%406M | 26.01%218M | -43.09%173M | 36.32%304M | 62.77%223M | 90.28%137M |
Net changes in other investments | 94.50%-11M | -173.97%-200M | -255.32%-73M | -17.54%47M | 122.71%57M | -512.20%-251M | -135.96%-41M | 172.61%114M | -108.76%-157M | 915.00%1.79B |
Investing cash flow | 62.61%-1.82B | -120.97%-4.86B | -93.83%-2.2B | 29.13%-1.13B | 29.82%-1.6B | -9.04%-2.28B | -5.77%-2.09B | 12.79%-1.98B | -85.06%-2.27B | 14.22%-1.23B |
Financing cash flow | ||||||||||
Net issuance payments of debt | ---100M | --0 | --0 | --100M | ---- | -55.27%-1.43B | -22.96%-921M | 18.59%-749M | 5.15%-920M | -155.59%-970M |
Net common stock issuance | --0 | --0 | --0 | 50.00%-1M | -100.00%-2M | 99.90%-1M | -49,900.00%-1B | ---2M | --0 | ---1M |
Increase or decrease of lease financing | -2.56%-360M | -7.01%-351M | -13.89%-328M | -25.76%-288M | -47.74%-229M | -38.39%-155M | -47.37%-112M | -8.57%-76M | 33.33%-70M | 17.32%-105M |
Cash dividends paid | -35.90%-1.87B | -0.22%-1.38B | -16.85%-1.37B | -33.52%-1.18B | -20.05%-880M | 2.79%-733M | -7.10%-754M | -39.96%-704M | 0.00%-503M | 0.00%-503M |
Cash dividends for minorities | 39.47%-23M | 77.51%-38M | -42.02%-169M | -36.78%-119M | -17.57%-87M | -2.78%-74M | -44.00%-72M | 10.71%-50M | 5.08%-56M | -37.21%-59M |
Net other fund-raising expenses | 99.94%-1M | 74.03%-1.76B | -676,100.00%-6.76B | 50.00%-1M | 0.00%-2M | 0.00%-2M | -100.00%-2M | 50.00%-1M | -100.00%-2M | 50.00%-1M |
Financing cash flow | 33.14%-2.35B | 59.21%-3.52B | -481.67%-8.63B | -23.67%-1.48B | 49.90%-1.2B | 16.29%-2.4B | -80.85%-2.86B | -2.00%-1.58B | 5.37%-1.55B | -253.18%-1.64B |
Net cash flow | ||||||||||
Beginning cash position | -3.73%25.57B | -37.85%26.56B | 71.70%42.74B | 51.95%24.89B | 5.46%16.38B | -32.31%15.53B | 5.03%22.95B | 15.19%21.85B | 16.41%18.97B | 57.12%16.29B |
Current changes in cash | 161.32%680M | 93.17%-1.11B | -191.06%-16.24B | 109.38%17.84B | 881.57%8.52B | 111.69%868M | -806.76%-7.43B | -65.94%1.05B | 23.14%3.09B | -56.91%2.51B |
Effect of exchange rate changes | --34M | --0 | 688.89%71M | 190.00%9M | 44.44%-10M | -212.50%-18M | -67.35%16M | 124.02%49M | -222.16%-204M | 518.52%167M |
Cash adjustments other than cash changes | ---- | 11,900.00%118M | 0.00%-1M | ---1M | ---- | -100.00%-2M | 50.00%-1M | -100.00%-2M | ---1M | ---- |
End cash Position | 2.79%26.29B | -3.73%25.57B | -37.85%26.56B | 71.70%42.74B | 51.95%24.89B | 5.46%16.38B | -32.31%15.53B | 5.03%22.95B | 15.19%21.85B | 16.41%18.97B |
Free cash flow | -45.92%2.87B | 169.29%5.31B | -140.85%-7.66B | 94.73%18.76B | 135.73%9.63B | 190.38%4.09B | -277.64%-4.52B | -47.31%2.55B | 35.90%4.83B | -13.59%3.55B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |